Investing.com - Autobio Diagnostics reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Autobio Diagnostics announced earnings per share of ¥0.63 on revenue of ¥1.21. Analysts polled by Investing.com anticipated EPS of ¥0.66 on revenue of ¥1.37B.
Autobio Diagnostics shares are down 26% from the beginning of the year and are trading at ¥73.60 , down-from-52-week-high.
Autobio Diagnostics follows other major Healthcare sector earnings this month
Autobio Diagnostics's report follows an earnings missed by Aier Eye Hospital Group on Wednesday, who reported EPS of ¥0.15 on revenue of ¥4.94B, compared to forecasts EPS of ¥0.1722 on revenue of ¥5.7B.
Imeik had missed expectations on Wednesday with third quarter EPS of ¥1.85 on revenue of ¥604.5M, compared to forecast for EPS of ¥1.95 on revenue of ¥692.11M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar